ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease
- 1 May 2001
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 120 (6) , 1347-1355
- https://doi.org/10.1053/gast.2001.23966
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- ASCA and panca do not predict response to anti-TNFA (Remicade®) treatmentGastroenterology, 2000
- Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich ElementsImmunity, 1999
- Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitisPublished by Elsevier ,1999
- Severe Malarial Anemia and Cerebral Malaria Are Associated with Different Tumor Necrosis Factor Promoter AllelesThe Journal of Infectious Diseases, 1999
- Variation in the Tumor Necrosis Factor- Gene Promoter Region May Be Associated with Death from Meningococcal DiseaseThe Journal of Infectious Diseases, 1996
- Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.Journal of Clinical Investigation, 1996
- Role of Lymphotoxin and the Type I TNF Receptor in the Formation of Germinal CentersScience, 1996
- Variation in the TNF-α promoter region associated with susceptibility to cerebral malariaNature, 1994
- Highly Informative Typing of the Human TNF Locus Using Six Adjacent Polymorphic MarkersGenomics, 1993
- Single base polymorphism in the human Tumour Necrosis Factor alpha (TNFα) gene detectable by Ncol restriction of PCR productHuman Molecular Genetics, 1992